Skip to main content

Want a detailed portfolio tracker?

Genprex (GNPX) P/E (2018 - 2026)

Genprex (GNPX) P/E from Mar 29, 2018 to Jul 21, 2026. The TTM Genprex (GNPX) P/E is -0.64. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Genprex (GNPX)

YearP/EChange
2026-0.64-66.64%
2025-1.91-95.67%
2024-44.07-87.01%
2023-339.33-86.70%
2022-2.55K-3.91%
2021-2.66K-65.52%
2020-7.70K+1728.28%
2019-421.26-69.66%
2018-1.39KN/A

Comparison Genprex (GNPX) P/E with competitors

Genprex (GNPX) P/E is -0.64.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.27%
NBYStablecoin Development Corp0.00-100.68%
ENLVEnlivex Ltd0.07-111.75%
FGENFibroGen Inc0.24-137.71%
CHRSCoherus Biosciences Inc0.85-233.29%
FBIOFortress Biotech Inc0.95-249.08%
ORMPOramed Pharmaceuticals Inc1.50-336.11%
AGENAgenus Inc3.01-572.77%
INVAInnoviva Inc3.15-595.46%
VXRTVaxart Inc3.55-657.62%
CRMDCorMedix Inc3.63-669.98%
CVACCureVac N.V.4.45-798.36%
GLPGGalapagos NV4.86-863.27%
SRPTSarepta Therapeutics Inc4.88-866.92%
ABEOAbeona Therapeutics Inc5.39-946.31%
ABUSArbutus Biopharma Corp5.60-979.00%
ZVRAZevra Therapeutics Inc5.89-1024.81%
SPROSpero Therapeutics Inc6.23-1078.41%
CGENCompugen Ltd6.31-1091.85%
RIGLRigel Pharmaceuticals6.87-1179.52%
SLXNSilexion Therapeutics Corp7.30-1246.13%
OMEROmeros Corporation9.26-1554.44%
AUPHAurinia Pharmaceuticals Inc9.58-1605.68%
PLXProtalix BioTherapeutics Inc10.89-1810.85%
ACADAcadia Pharmaceuticals Inc11.73-1942.42%
TBPHTheravance Biopharma Inc12.26-2026.24%
ADMAAdma Biologics Inc12.42-2050.75%
HRMYHarmony Biosciences Holdings Inc13.82-2270.99%
SABSSAB Biotherapeutics Inc14.14-2320.64%
NAGENiagen Bioscience Inc14.82-2427.76%
INCYIncyte Corp15.82-2585.54%
REGNRegeneron Pharmaceuticals Inc15.86-2590.90%
PBYIPuma Biotechnology Inc17.32-2820.10%
CPRXCatalyst Pharmaceuticals Inc17.44-2839.52%
EXELExelixis Inc17.54-2855.02%
TGTXTG Therapeutics Inc18.97-3079.35%
MDXGMimedx Group Inc20.55-3328.57%
XOMAXOMA Royalty Corp22.87-3693.45%
ARGXArgen X SE24.30-3917.04%
CTMXCytomX Therapeutics Inc24.82-3999.22%
XOMAOXOMA Royalty Corp25.34-4081.49%
HALOHalozyme Therapeutics Inc25.62-4125.30%
XOMAPXOMA Royalty Corp25.67-4132.59%
VRTXVertex Pharmaceuticals Inc27.99-4497.77%
RPRXRoyalty Pharma plc - Class A28.69-4606.61%
SLNOSoleno Therapeutics Inc29.02-4658.10%
ASNDAscendis Pharma A/S30.09-4826.22%
LGNDLigand Pharmaceuticals Inc - Class B37.91-6055.71%
APLSApellis Pharmaceuticals Inc39.02-6229.96%
BMRNBiomarin Pharmaceutical Inc42.21-6731.18%
KRYSKrystal Biotech Inc45.34-7223.14%
ONCBeiGene Ltd69.54-11024.31%
PHARPharming Group N.V.75.03-11885.99%
TECHBio-Techne Corp101.96-16116.94%
VCELVericel Corp109.92-17367.87%
ALNYAlnylam Pharmaceuticals Inc117.96-18631.49%
GMABGenmab140.29-22138.69%
TLXTelix Pharmaceuticals Ltd162.15-25573.07%
CORTCorcept Therapeutics Inc212.86-33538.42%